Results 161 to 170 of about 56,249 (222)

Efficacy and safety of Shenqi Yangxin formula in patients with stable coronary artery disease based on CCTA: rationale, design, and study protocol for a randomized, double-blind, placebo-controlled study. [PDF]

Front Cardiovasc Med
Zhang X, Liu Y, Sun J, Chen Y, Zhang X, Guo J, Ren H, Liu P, Wang C, Zhang D.   +9 more
europepmc   +1 more source

RNA modifications in peripheral blood are associated with acute coronary syndrome. [PDF]

J Mol Cell Cardiol Plus
Sopic M, Stopa V, Munjas J, Davidović A, Vukmirović L, Cvijanović D, Milanov M, Martelli F, Bernardin F, Legrave NM, Devaux Y.   +10 more
europepmc   +1 more source

Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events. [PDF]

Front Pharmacol
Chen D, Wang Z, Xie Z, Chen Y, Luo S, Xu S.   +5 more
europepmc   +1 more source

Randomized controlled trial of vericiguat in patients with coronary microvascular dysfunction causing stable chest pain (V-COM): study protocol for a randomized control trial. [PDF]

J Cardiovasc Magn Reson
Lo CK, Ip NH, Sin TH, Ho SY, Wong CK, Tam FC, Lam SC, Yiu KH, Sze MS, Lam TT, Chiu ACH, Li KK, Un KC, Yu EY, Chan EK, Lee KK, Ching S, Lee DP, Wong CY, Chan HL, Chan NY, Leung CY, Ng MY.   +22 more
europepmc   +1 more source

Giant right atrial Myxoma associated with acute coronary syndrome. [PDF]

Oxf Med Case Reports
Hibatouallah H, Mehssani Z, Sayah R, Fellat R, Fellat N.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PCI for stable angina

Nature Reviews Cardiology, 2023
Gregory Lim
exaly   +3 more sources